548. Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with moderate COVID-19

BACKGROUND: Remdesivir (RDV) has been shown to shorten recovery time and was well tolerated in patients with severe COVID-19. Here we report baseline characteristics associated with clinical improvement at day (d) 14. METHODS: We enrolled hospitalized patients with confirmed SARS-CoV-2 infection, ox...

Descripción completa

Detalles Bibliográficos
Autores principales: Castagna, Antonella, Hui, David Shu Cheong, Mullane, Kathleen M, Jain, Mamta, Galli, Massimo, Chang, Shan-Chwen, Hyland, Robert H, SenGupta, Devi, Cao, Huyen, Huang, Hailin, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Lübbert, Christoph, Lye, David Chien Boon, Aberg, Judith A, Elorza, Enrique Navas, Tashima, Karen T, McPhail, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778131/
http://dx.doi.org/10.1093/ofid/ofaa439.742

Ejemplares similares

Ejemplares similares